Patient Population Under Consideration
This recommendation applies to all children 1 to 5 years of age.
Screening Tests
Various screening tests that are feasible in primary care are used to
identify visual impairment among children. These tests include visual
acuity tests, stereoacuity tests, the cover-uncover test, and the
Hirschberg light reflex test (for ocular alignment/strabismus), as well
as the use of autorefractors (automated optical instruments that detect
refractive errors) and photoscreeners (instruments that detect
amblyogenic risk factors and refractive errors).
Treatment
Primary treatment for amblyopia includes the use of corrective
lenses, patching, or atropine treatment of the nonaffected eye.
Treatment may consist of a combination of interventions.
Suggestions for Practice Regarding I Statement
In deciding whether to refer children <3 years of age for screening, clinicians should consider the following.
Potential Preventable Burden
Most studies show that screening and treatment later in the preschool
years seem to be as effective at preventing amblyopia as screening and
treatment earlier in life.
Costs
Potential disadvantages of using photoscreeners and autorefractors
are the initial high costs associated with the instruments and the need
for external interpretation of screening results with some
photoscreeners.
Current Practice
Typical components of vision screening include assessments of visual
acuity, strabismus, and stereoacuity. Younger children often are unable
to cooperate with some of the screening tests performed in clinical
practice, such as visual acuity testing. Steroacuity testing often is
omitted and may be performed incorrectly when attempted. Screening of
younger children may be difficult and often yields false-positive
results because of the child's inability to cooperate with testing.
Children with positive findings should be referred for a full
ophthalmologic examination, to confirm the presence of vision problems,
and further treatment.
Screening Intervals
The USPSTF did not find adequate evidence to determine the optimal screening interval.